Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Olthoff

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Acta Anaesthesiologica Scandinavica|August 1, 1997
Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled studyK Korttila, F Clergue, J Leeser, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 9, 1998
[Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997]E Hartung, M Anetseder, D Olthoff, et al.
Critical Care Medicine|November 9, 2001
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation studyE Abraham, K Reinhart, P Svoboda, et al.
European Journal of Human Genetics : EJHG|April 18, 2003
Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?R L Robinson, M J Anetseder, V Brancadoro, et al.
Der Anaesthesist|June 28, 2008
[Study protocol of the VISEP study. Response of the SepNet study group]K Reinhart, F M Brunkhorst, C Engel, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Acta Anaesthesiologica Scandinavica|August 1, 1997
Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled studyK Korttila, F Clergue, J Leeser, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 9, 1998
[Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997]E Hartung, M Anetseder, D Olthoff, et al.
Critical Care Medicine|November 9, 2001
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation studyE Abraham, K Reinhart, P Svoboda, et al.
European Journal of Human Genetics : EJHG|April 18, 2003
Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?R L Robinson, M J Anetseder, V Brancadoro, et al.
Der Anaesthesist|June 28, 2008
[Study protocol of the VISEP study. Response of the SepNet study group]K Reinhart, F M Brunkhorst, C Engel, et al.
Pageof 10